Brookdale Senior Living Inc.
HealthcareNYSE:BKD · New York Stock Exchange
+$0.49 today
Vol 2.99M · Avg 3.49M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$262.7M -30.1% | -$202.0M -6.9% | -$189.0M +20.7% | -$238.3M -139.9% | -$99.4M | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $370.3M +0.8% | $367.5M +4.9% | $350.4M -1.0% | $353.9M +2.6% | $345.1M | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | -$3.3M -190.9% | $3.6M -52.3% | $7.6M +673.3% | -$1.3M +86.5% | -$9.8M | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $11.9M -15.8% | $14.2M +18.3% | $12.0M -17.2% | $14.5M -11.1% | $16.3M | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | $1.2M -90.2% | $12.2M -69.9% | $40.6M +198.5% | -$41.3M +18.3% | -$50.5M | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | -$15.8M -351.3% | -$3.5M -147.4% | $7.4M +259.6% | -$4.6M -1021.1% | $502.0K | $592.6M | $1.3B | $626.2M |
| Inventory | $0 | $0 | $0 | $0 -100.0% | $54.0M | $1.0B | $1.2B | $1.1B |
| Accounts Payables | $0 -100.0% | $15.7M +541.2% | $2.4M +109.0% | -$27.2M +49.7% | -$54.0M | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | $17.0M +73752.2% | $23.0K -99.9% | $30.8M +425.9% | -$9.5M +81.5% | -$51.0M | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | $100.6M +442.7% | -$29.4M +50.0% | -$58.7M +30.2% | -$84.1M +71.6% | -$296.3M | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | $218.0M +31.2% | $166.2M +2.0% | $162.9M +4865.7% | $3.3M +103.5% | -$94.6M | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$512.6M -154.7% | -$201.3M +13.7% | -$233.2M -18.4% | -$196.9M -11.5% | -$176.7M | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | $0 +100.0% | -$101.4M -1236.1% | -$7.6M -3381.2% | -$218.0K +96.0% | -$5.4M | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | $0 +100.0% | -$49.1M +73.8% | -$186.9M +29.1% | -$263.7M +27.2% | -$362.3M | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $0 -100.0% | $80.6M -61.1% | $207.0M -48.1% | $398.8M +13.0% | $353.0M | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $56.6M +127.2% | -$208.2M -292.9% | $107.9M +2110.1% | -$5.4M -101.4% | $372.8M | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | -$456.0M -64.0% | -$278.1M -145.3% | -$113.4M -68.1% | -$67.4M -137.2% | $181.5M | $4.8B | $6.4B | $5.1B |
| Debt Repayment | $225.7M +32.3% | $170.7M +205.5% | -$161.7M -500.5% | -$26.9M +69.6% | -$88.6M | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $0 | $0 | $0 -100.0% | $139.4M | $0 | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | -$6.5M -88.3% | -$3.4M -79.5% | -$1.9M | $0 +100.0% | -$4.8M | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | -$18.1M +27.9% | -$25.2M -132.3% | -$10.8M -108.2% | $131.6M +750.6% | -$20.2M | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | $201.1M +41.6% | $142.1M +181.4% | -$174.4M -273.8% | $100.4M +188.3% | -$113.7M | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $0 | $0 | $0 | $0 | $0 | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | -$36.8M -222.1% | $30.2M +124.2% | -$124.9M -444.6% | $36.2M +235.0% | -$26.8M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | -$294.5M -739.7% | -$35.1M +50.1% | -$70.3M +63.7% | -$193.6M +28.6% | -$271.3M | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
ImmunityBio, Inc.
NASDAQ:IBRX
$7.44B
Cogent Biosciences, Inc.
NASDAQ:COGT
$5.66B
Denali Therapeutics Inc.
NASDAQ:DNLI
$3.44B
National HealthCare Corporation
AMEX:NHC
$3.09B
Arcus Biosciences, Inc.
NYSE:RCUS
$2.40B
Acadia Healthcare Company, Inc.
NASDAQ:ACHC
$2.26B
89bio, Inc.
ETNB
$2.20B
Addus HomeCare Corporation
NASDAQ:ADUS
$1.74B
Aveanna Healthcare Holdings Inc.
NASDAQ:AVAH
$1.54B
Ardent Health Partners, LLC
NYSE:ARDT
$1.34B
SEC Filings
Recent regulatory filings
No filings found.
Does BKD generate free cash flow?
Brookdale Senior Living Inc. (BKD) generated -$294,523,000.00 of free cash flow in fiscal 2025.
How much operating cash flow does BKD produce?
Operating cash flow was $218.03M, before capital expenditures of $512.55M.
Explore More
Continue the stock analysis
Jump to another research area for this company.